Skip to main content
. Author manuscript; available in PMC: 2015 Sep 12.
Published in final edited form as: J Proteomics Bioinform. 2014 Sep 12;7(10):296–302. doi: 10.4172/jpb.1000332

Figure 4. Boxplots represent changes of CD90 expression during hepatocarcinogenesis.

Figure 4

(A) Percentage of CD90 cancer cells/hepatocytes, (B) level of CD90 expression in tumor region, and (D) level of overall expression increased significantly during disease progression.

(C) Though levels of CD90 expression in stroma were significantly different among different disease categories, they did not show an increasing trend during heptocarcinogenesis.

(Normal n=15, Cirrhosis n=21, Early-stage HCC n=67, Late-stage HCC n=82)

Inserted table: ‘multiple linear regression’ refers to the analysis where the group is treated as an ordinal variable; ‘ANCOVA’ (analysis of covariance) refers to the adjusted analysis where the group is treated as categorical variable.